Look at a map of Great Lakes states and their cannabis laws. Michigan: full recreational. Illinois: full recreational. Minnesota: full recreational. Indiana: limited, but moving. Ohio: recreational since 2023.
Wisconsin: nothing.
Not medical. Not decriminalization with any real teeth. Just a technical civil forfeiture for first-offense possession under 25 grams, and a CBD-only provision for seizure patients that barely qualifies as a program.
For years, Wisconsin has been the stubborn anomaly — a purple-trending state where a Republican-controlled legislature has blocked every cannabis reform attempt while neighboring states built billion-dollar markets and brought in hundreds of millions in tax revenue. But something shifted in 2025, and the state may finally be moving.
What Changed: Felzkowski
The most significant development is who is now backing medical cannabis in the state Senate. Senate President Mary Felzkowski, a Republican from Irma who once represented exactly the kind of rural, conservative constituency that has kept Wisconsin’s cannabis laws frozen, introduced a companion bill to the Assembly’s medical cannabis legislation — AB 547.
That’s not a small thing. The Senate President introducing a medical cannabis bill represents a meaningful break from the caucus’s default position. Felzkowski framed the issue in terms of patient access and economic development, arguments that resonate differently when they come from a conservative leader rather than a Democratic governor pushing cannabis in a budget proposal.
AB 547 would create a narrower, medical-only program — not adult-use, not decriminalization, just a structured pathway for patients with qualifying conditions to access cannabis legally. Governor Tony Evers, who has repeatedly included cannabis provisions in his budget proposals only to see Republicans strip them out, has indicated he would sign a medical bill that doesn’t include provisions designed to kill it.
Why the Timing Matters
Wisconsin is losing on multiple fronts simultaneously.
The tax revenue argument has gotten impossible to ignore. Illinois is collecting hundreds of millions annually from cannabis sales. Michigan’s market topped $3 billion. Many of those sales are happening near the Wisconsin border — residents crossing state lines to buy legally what they’d consume back home.
The jobs and economic development argument has gotten sharper too. Cannabis businesses create cultivation jobs, retail jobs, processing jobs, and ancillary employment. Wisconsin’s neighboring states are building that workforce while Wisconsin’s legislature debates whether to allow patients to access medicine.
And the polling argument has been consistent for years: more than 60% of Wisconsin residents support medical cannabis, and the number supporting broader reform is growing. Republicans from competitive districts feel that pressure.
What AB 547 Would Actually Do
The medical cannabis bill would establish a formal registry program for qualifying patients, create a licensing framework for cultivators and dispensaries, and give patients with serious conditions — cancer, epilepsy, chronic pain, PTSD, and others — legal access to cannabis medicine.
Wisconsin currently has nothing equivalent. The CBD provision allows a physician to certify that a patient may possess CBD oil for seizures, but there’s no legal way to obtain it in-state. The state’s first medical dispensary has never opened because there’s no medical program to operate under.
AB 547 changes that. If it advances, Wisconsin patients would have a legal pathway to purchase regulated medicine from licensed dispensaries — the same baseline that 38 other states already provide.
There’s also a comprehensive legalization bill, AB 1061, introduced in March 2026, but that faces a harder path through the Republican-controlled Assembly. The realistic near-term target is medical.
The Path Forward
The medical bill has Senate President backing, a supportive governor, and a public that’s ready. The remaining obstacle is Assembly Republican leadership, which has historically aligned with law enforcement groups that have opposed any cannabis reform in Wisconsin.
That opposition has quieted somewhat as the political calculus has shifted — it’s harder to campaign on blocking medicine for patients when your neighboring state just opened its 500th dispensary. But harder isn’t impossible, and the Assembly hasn’t committed to moving the bill.
The next few months of the Wisconsin legislative session will be telling. If Felzkowski’s backing generates enough Senate momentum to force a floor vote, Assembly leadership faces a choice: let it happen, or be seen blocking bipartisan medical cannabis reform while 60% of the state wants it.
Track AB 547 and follow Wisconsin cannabis legislation at cannabisinquirer.com/legislative-tracker/.
Related Stories
Responses